Market revenue in 2022 | USD 84.4 million |
Market revenue in 2030 | USD 198.5 million |
Growth rate | 11.3% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Services |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Abcam PLC, Enzon Pharmaceuticals Inc, Merck KGaA, Caribou Biosciences Inc Ordinary Shares, NOF Corp, Caleres Inc, Creative PEGWorks, Aurigene Pharmaceutical Services, Laysan Bio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pegylated proteins market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.34% in 2022. Horizon Databook has segmented the UK pegylated proteins market based on consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK pegylated proteins market , including forecasts for subscribers. This country databook contains high-level insights into UK pegylated proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account